- Home
- News
- us virgislands
- inflammatory activation
Inflammatory Activation Articles & Analysis
23 news found
Exosomes derived from animal, plant, and microbial sources exhibit certain biological activities, such as anti-inflammatory, antioxidant, whitening, and anticancer properties. ...
Pulmonary arterial hypertension (PAH) is a progressive, life-threatening condition characterized by increased pulmonary arterial pressure, vascular remodeling, and persistent inflammation. Despite advances in treatment, current therapies—such as sildenafil, iloprost, and riociguat—primarily focus on reducing symptoms by dilating blood vessels. Unfortunately, these therapies do ...
Phenylpropanoids are explored for their potential as antioxidants, UV protectants, and anti-inflammatory agents. Their versatility extends to applications in cancer treatment and wound healing, making them a significant focus of biotechnological research. ...
As one of the leading chemical manufacturers and suppliers globally, Alfa Chemistry is well-prepared to provide a number of active pharmaceutical ingredients (APIs), such as donepezil and dexmedetomidine hydrochloride, for customers worldwide ranging from lab to commercial scale. ...
Incentives that come with the designation include eligibility for federal grants, research and development tax credits, a waiver of prescription drug user fees, and the potential for a 7-year market exclusivity period upon FDA approval. BRM424 uses the same active pharmaceutical ingredient (API) as BRM421, BRIM’s lead candidate for Dry Eye Disease which is about to begin ...
Walnut peptide Walnut peptides have been reported with anti-inflammatory, antioxidant, anticancer, and anti-hypertensive activities. ...
Ex vivo studies show that treatment with IO-108 produces pro-inflammatory activity and an enhanced antigen-presenting cell (APC) phenotype to multiple stimuli, including T cell activators, and STING and TLR agonists. As a single agent, IO-108 reverts the anti-inflammatory myeloid cell phenotype caused by “tumor ...
Do not administer ABECMA to patients with active infection or inflammatory disorders. Treat severe or life-threatening CRS with tocilizumab or tocilizumab and corticosteroids. ...
SetPoint Medical’s bioelectronic medicine platform is intended to offer patients and providers a treatment alternative for rheumatoid arthritis, inflammatory bowel disease and other chronic autoimmune conditions with potentially less risk and cost than drug therapy. The company is developing a novel bioelectronic medicine platform designed to stimulate the vagus nerve to ...
The randomized, placebo-controlled, double-blind trial will evaluate the efficacy, tolerability and safety of ESO-101 in 42 adult patients with active eosinophilic esophagitis (EoE), in four European countries. Patients will be randomized 2:1 and will be treated for 28 days. ...
Key data from the first-in-human FORTITUDE trial shows that a single cycle of intravenous (IV) NG-350A drives dose-dependent increases in specific inflammatory biomarkers, consistent with the mechanism of the encoded anti- CD40 agonist. ...
The first prize in this category was won by PerFormS, a start-up from Modena which has developed the first alternative drug to cortisone for the long-term treatment of psoriasis, enhancing the anti-inflammatory activity of an endogenous molecule with no side effects. ...
The company is pioneering a new treatment paradigm, using electrical pulses that activate the body’s innate “inflammatory reflex,” for rheumatoid arthritis (RA), Crohn’s disease and other chronic autoimmune diseases as a safe, cost-effective alternative to drugs and biologics. “SetPoint is reshaping the treatment paradigm of chronic ...
Finally, probiotics can modify the immune response by regulating the secretion of anti-inflammatory cytokines, thereby reducing gastric activity and inflammation. ...
Patients with eosinophilic esophagitis (EoE) suffer from severe symptoms including swallowing disorders, food impaction, vomiting, and heartburn EsoCap is currently conducting a randomized, placebo-controlled, double-blind Phase II trial to treat 42 patients in four European countries with its lead candidate ESO-101 To help raise awareness of the medical condition, EsoCap supports EUREOS and ...
SetPoint Medical’s bioelectronic medicine platform is intended to offer patients and providers a treatment alternative for rheumatoid arthritis, inflammatory bowel disease and other chronic autoimmune conditions with potentially less risk and cost than drug therapy. The company is developing a novel bioelectronic medicine platform that stimulates the vagus nerve to ...
SetPoint’s investigational bioelectronic medicine platform stimulates the vagus nerve to activate the endogenous inflammatory reflex and thereby reduce inflammation. ...
” “These new data confirm that activation of the cholinergic anti-inflammatory pathway by vagus nerve stimulation can reduce disease activity even in patients who have failed to respond to multiple classes of biological drugs and JAK inhibitors,” said Dr. ...
” “These new data confirm that activation of the cholinergic anti-inflammatory pathway by vagus nerve stimulation can reduce disease activity even in patients who have failed to respond to multiple classes of biological drugs and JAK inhibitors,” said Dr. ...
SetPoint Medical’s bioelectronic medicine platform is intended to offer patients and providers a treatment alternative for rheumatoid arthritis, inflammatory bowel disease and other chronic autoimmune conditions with potentially less risk and cost than drug therapy. The company is developing a novel bioelectronic medicine platform that stimulates the vagus nerve to ...